Use of proton pump inhibitors and risk of hip fracture in relation to dietary and lifestyle factors: a prospective cohort study
about
Nutritional strategies for skeletal and cardiovascular health: hard bones, soft arteries, rather than vice versaNonsteroidal anti-inflammatory drugs, gastroprotection, and benefit-riskEsomeprazole and aspirin fixed combination for the prevention of cardiovascular eventsChronic proton pump inihibitor therapy and calcium metabolismAnti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials.Likelihood ratio based tests for longitudinal drug safety data.Perils and pitfalls of long-term effects of proton pump inhibitors.Proton Pump Inhibitors and the Risk for Fracture at Specific Sites: Data Mining of the FDA Adverse Event Reporting System.Calcium and vitamin D supplementation: state of the art for daily practicePredictors of atypical femoral fractures during long term bisphosphonate therapy: a case series & review of literatureLong-term efficacy and safety of rabeprazole in patients taking low-dose aspirin with a history of peptic ulcers: a phase 2/3, randomized, parallel-group, multicenter, extension clinical trialPotential protective effects of Clostridium butyricum on experimental gastric ulcers in miceAcid-suppressive medications and risk of fracture: an updated meta-analysis.The Indications, Applications, and Risks of Proton Pump InhibitorsRisk of dementia from proton pump inhibitor use in Asian population: A nationwide cohort study in Taiwan.Changing trends in the epidemiology of hip fracture in Spain.Canadian Association of Gastroenterology position statement: hip fracture and proton pump inhibitor therapy-a 2013 update.Does serum calcium relate to different types of hip fracture? A retrospective study.Lifestyle factors among proton pump inhibitor users and nonusers: a cross-sectional study in a population-based setting.The relationship between proton pump inhibitor use and longitudinal change in bone mineral density: a population-based study [corrected] from the Canadian Multicentre Osteoporosis Study (CaMos).Inflammatory bowel disease, high-dose steroids, osteoporosis, or an oncological etiology for a pathological femoral neck fracture in a young adult: a case report.Use of proton pump inhibitors and subsequent risk of celiac diseaseFailure of proton pump inhibitors to treat GERD in neonates and infants: a question of drug, diagnosis, or design.Pharmacokinetic and clinical evaluation of esomeprazole and ASA for the prevention of gastroduodenal ulcers in cardiovascular patients.The role of the gastrointestinal tract in calcium homeostasis and bone remodeling.Fundoplication versus medical management of gastroesophageal reflux disease: systematic review and meta-analysis.Pharmacokinetic evaluation of esomeprazole for the treatment of gastroesophageal reflux disease.Stress ulceration: prevalence, pathology and association with adverse outcomes.Adverse skeletal effects of drugs - beyond Glucocorticoids.A biomechanical sorting of clinical risk factors affecting osteoporotic hip fracture.Association Between Proton Pump Inhibitor Use and Cognitive Function in Women.A Proton Pump Inhibitor in the Reformulation Setting: Bioequivalence and Potential Implications for Long-Term Safety.Correlation between proton pump inhibitors and risk of pyogenic liver abscess.Adverse effects of proton-pump inhibitor use in older adults: a review of the evidence.Decrease of Estradiol and Several Lifestyle Factors, but Not Helicobacter pylori Infection, Are Significant Risks for Osteopenia in Japanese Females.[Long-term use of proton pump inhibitors: who needs prophylaxis?].Proton pump inhibitors and risk of bone fractures.Long-term follow up in patients with gastroesophageal reflux disease with specific emphasis on reflux symptoms, use of anti-reflux medication and anti-reflux surgery outcome: a retrospective study.No Significant Association Between Proton Pump Inhibitor Use and Risk of Stroke After Adjustment for Lifestyle Factors and Indication.Risk of dementia in elderly patients with the use of proton pump inhibitors.
P2860
Q26752732-4D2EED67-D646-4A85-B24C-0D9D46633921Q26864640-26E6D66A-2204-45BE-9EE8-76F1B157E4FAQ26995752-15DBEA7B-258E-4D02-A0F0-46947F2F91ACQ27016636-187D477C-E3A7-4627-B11D-E6637B475786Q30412203-37E21389-F46C-4877-950B-CAE61236FC2FQ30830496-8D885767-CBDE-4913-BC0E-3FE42DFF02E1Q33409626-E0C281B5-0DC4-478C-938F-D9632C5FA8FAQ33912042-968CDDC0-17CE-481D-8FD4-EBC2708B4181Q34021383-9FE89AE4-C1D4-49E4-BDD4-EABDB3EA59B2Q34272136-D7E72558-DF52-4E60-9C62-E4DDD3C62B51Q35678985-3E01AD47-1291-4C32-852A-31559768A5FEQ35865246-80139EF7-9327-477E-9F76-CCFEBC783E29Q35959430-44C16CB5-B4E1-48FF-B47F-5A381EA003FCQ36091187-DFF51BC6-2BD4-40FB-AD52-EF7C715A28FDQ36281192-AC977216-08BE-4A24-962B-845D7EE287B8Q36961288-C37A50E9-7013-4F04-A89B-FB36B334DAC5Q37247769-BF73AF15-B0E5-4788-9C27-B1EE6CC1B435Q37346611-34F6A4E0-275F-4115-B916-1589FCB71F0DQ37378002-F5BB97CC-0252-470B-AA47-FF7ADD8F82FEQ37407767-82E9AEB6-6AE0-479A-B228-DB66CA484001Q37614903-638F2992-337C-41B7-AB36-469C5CF0B87DQ37625863-F1904550-443D-4BC1-95E8-405546FD59C7Q38026988-BFDD1772-85D1-4045-9A94-839B081308D8Q38030989-03C0FC63-4EB0-46AC-BB64-015536ABF12FQ38093799-90DFC8C0-499E-4BB4-A981-EFEFF336DC5EQ38135722-C6E752E8-9269-4B6D-95D7-A18C3B656BC0Q38229080-DACEED8B-BCAC-49C4-8BEC-EC7C41C594EAQ38230155-5D85EBA1-AB00-47A1-870A-191C40B12B95Q38231316-C4002AF2-31EC-426D-B290-BEC941B99177Q38585164-CD61C2E3-45C7-4FD2-99CF-12D8A7F6E91FQ38669442-04EBB283-BF1B-4552-BD37-EBEC95EB9CCAQ38724116-75A7DE5C-348C-41B8-BB61-DB4F6B13DCC8Q38824710-A31F17AA-6E74-43F6-8B0A-78E28902394FQ40071378-B4A9723E-1593-46E3-9146-2AD0E7DA8C61Q40101911-33715592-2096-4EE4-A313-CA2B7E31BF63Q43408318-7C889337-7389-4BD5-B781-901FB7254C68Q43426137-8E77797A-25F0-4608-AA85-C1FE4A86AD8DQ46610233-854A3085-CDD5-4DF2-8757-767B784A9D1CQ47264184-D1BCE394-5E13-4D03-B37A-6697D67807A6Q48186791-13131F65-4D87-4BCD-A94A-D1697AE2355B
P2860
Use of proton pump inhibitors and risk of hip fracture in relation to dietary and lifestyle factors: a prospective cohort study
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Use of proton pump inhibitors ...... rs: a prospective cohort study
@ast
Use of proton pump inhibitors ...... rs: a prospective cohort study
@en
type
label
Use of proton pump inhibitors ...... rs: a prospective cohort study
@ast
Use of proton pump inhibitors ...... rs: a prospective cohort study
@en
prefLabel
Use of proton pump inhibitors ...... rs: a prospective cohort study
@ast
Use of proton pump inhibitors ...... rs: a prospective cohort study
@en
P2093
P2860
P356
P1433
P1476
Use of proton pump inhibitors ...... rs: a prospective cohort study
@en
P2093
Andrew T Chan
Carlos A Camargo
Diane Feskanich
Edward S Huang
Hamed Khalili
P2860
P356
10.1136/BMJ.E372
P407
P577
2012-01-30T00:00:00Z